Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trigeminal Nerve Blockade for Cleft Palate Repair
NCT03632044Phase 4Active, not recruiting
- Sponsor
- University of Florida
- Start
- Nov 2018
- Primary completion
- May 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine in cleft palate, sponsored by University of Florida. Started Nov 2018; status: active, not recruiting.
02
Drugs
ropivacaine
03
Conditions
cleft palate
Beyond the preview
Go deeper on NCT03632044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03632044.